Table 1. Baseline demographics and clinical characteristics (N=21).
| Patient Characteristic | Total (%) |
|---|---|
| Age, years | |
| Median (Range) | 60 (23-80) |
| Gender | |
| Male | 13 (62%) |
| Female | 8 (38%) |
| ECOG performance status* | |
| 0 | 4 (19%) |
| 1 | 17 (81%) |
| Number of prior systemic therapies | |
| Median (Range) | 3 (1-6) |
| Number of prior temsirolimus | 2 (10%) |
| Number of prior bevacizumab | 4 (19%) |
| Number of prior cetuximab | 7 (33%) |
| Tumor type | |
| Colorectal | 1 |
| Squamous cell carcinoma head & neck | 9 (43%) |
| Melanoma | 2 (10%) |
| Chondrosarcoma | 1 |
| Cholangiocarcinoma | 1 |
| Mesothelioma | 1 |
| Cervical adenoma | 1 |
| Adenocarcinoma of tongue | 1 |
| Adenocarcinoma of Gastroesophageal Junction | 1 |
| Gastric adenocarcinoma | 1 |
| Adnexal carcinoma | 1 |
| Urethral carcinoma | 1 |
*
ECOG = Eastern Cooperative Oncology Group